NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr | ₹1,640 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹3,051 Cr |
Mar2023 | ₹2,317 Cr |
Mar2022 | ₹1,776 Cr |
Mar2021 | ₹1,819 Cr |
Mar2020 | ₹1,640 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹3,051 Cr | 31.65 | |
Mar2023 | ₹2,317 Cr | 30.45 | |
Mar2022 | ₹1,776 Cr | -2.36 | |
Mar2021 | ₹1,819 Cr | 10.91 | |
Mar2020 | ₹1,640 Cr | - |
Compare Net Current Assets of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,813.4 Cr | 7.2% | 5.5% | -15.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 7.2% |
5.5% |
-15.8% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses